Glaukos EBITDA Margin 2014-2022 | GKOS

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Glaukos (GKOS) over the last 10 years. The current EBITDA margin for Glaukos as of June 30, 2022 is .
Glaukos EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2022-06-30 $0.29B $0.00B 1.04%
2022-03-31 $0.29B $0.03B 8.50%
2021-12-31 $0.29B $0.00B 1.02%
2021-09-30 $0.29B $0.04B 12.59%
2021-06-30 $0.28B $0.02B 5.63%
2021-03-31 $0.24B $-0.02B -7.14%
2020-12-31 $0.23B $-0.06B -25.78%
2020-09-30 $0.22B $-0.10B -47.71%
2020-06-30 $0.21B $-0.11B -53.77%
2020-03-31 $0.24B $-0.08B -33.47%
2019-12-31 $0.24B $-0.04B -15.55%
2019-09-30 $0.23B $-0.01B -5.75%
2019-06-30 $0.21B $-0.01B -3.32%
2019-03-31 $0.20B $-0.01B -3.08%
2018-12-31 $0.18B $-0.01B -3.87%
2018-09-30 $0.17B $-0.01B -4.73%
2018-06-30 $0.17B $-0.00B -0.61%
2018-03-31 $0.16B 0 0.00%
2017-12-31 $0.16B $0.00B 1.89%
2017-09-30 $0.15B $0.00B 2.00%
2017-06-30 $0.14B $0.00B 2.14%
2017-03-31 $0.13B $0.01B 6.25%
2016-12-31 $0.12B $0.01B 7.83%
2016-09-30 $0.10B $0.01B 5.88%
2016-06-30 $0.09B $0.00B 3.30%
2016-03-31 $0.08B $-0.00B -5.00%
2015-12-31 $0.07B $-0.01B -8.33%
2015-09-30 $0.07B $-0.01B -13.64%
2015-06-30 $0.06B $-0.01B -15.25%
2015-03-31 $0.05B $-0.01B -11.54%
2014-12-31 $0.05B $-0.01B -20.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.385B $0.294B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.040B 20.78
Edwards Lifesciences (EW) United States $52.534B 37.17
Alcon (ALC) Switzerland $29.415B 24.91
STERIS (STE) Ireland $16.731B 20.78
Teleflex (TFX) United States $9.732B 15.51
Fresenius Medical Care AG KGaA (FMS) Germany $8.433B 7.78
Penumbra (PEN) United States $7.007B 840.64
Globus Medical (GMED) United States $5.801B 29.59
Integer Holdings (ITGR) United States $2.051B 16.04
Nevro (NVRO) United States $1.548B 0.00
Paragon 28 (FNA) United States $1.343B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.035B 15.85
Artivion (AORT) United States $0.537B 51.19